Methods of measuring body image disturbance in eating disorders: a scoping review protocol
Abstract
Introduction: Body image disturbance (BID) is a complex construct that includes cognitive-affective, perceptual and behavioural characteristics, influencing how people perceive and feel about their bodies. An accurate assessment of BID is important for identifying and treating eating disorders (EDs), debilitating psychiatric conditions that compromise individuals' well-being, leading to high death rates. Methods used to quantify BID in people with EDs vary widely, making it difficult to establish a gold standard measure. Hence, this scoping review will aim at summarising the literature on the methods to assess BID in people with EDs, providing a clearer overview of the topic.
Methods and analysis: The scoping review will map and synthesise the BID in individuals with EDs, exploring: (1) Which methods and tools are used to assess BID in individuals with EDs, and are they self-reported or evaluated by clinicians? (2) Which components of BID are assessed? (3) What are the main outcomes measured by these methods and tools? What is their validity, reliability and sensitivity? The population of interest will include individuals of all ages diagnosed with one of the main EDs: anorexia nervosa, bulimia nervosa and binge ED (BED). Hence, the concept of this review will revolve around the methods and tools for measuring BID in EDs focusing on research conducted either in experimental or clinical settings. Records will be screened by two independent reviewers and any discrepancies will…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.